Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1931 1
1933 1
1945 2
1946 1
1949 1
1950 2
1957 1
1958 1
1960 1
1962 3
1964 1
1966 1
1967 3
1969 1
1970 4
1971 1
1973 3
1974 1
1975 8
1976 10
1977 7
1978 7
1979 11
1980 11
1981 4
1982 5
1983 14
1984 16
1985 8
1986 21
1987 10
1988 15
1989 13
1990 23
1991 16
1992 13
1993 14
1994 20
1995 20
1996 8
1997 19
1998 17
1999 13
2000 9
2001 21
2002 20
2003 26
2004 21
2005 23
2006 24
2007 23
2008 22
2009 20
2010 21
2011 21
2012 25
2013 29
2014 39
2015 45
2016 53
2017 38
2018 36
2019 29
2020 687
2021 1061
2022 597
2023 327
2024 68

Text availability

Article attribute

Article type

Publication date

Search Results

3,314 results

Results by year

Filters applied: . Clear all
The following term was ignored: (
Page 1
Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection.
Kumar NR, Karanam VC, Kumar S, Kumar SD. Kumar NR, et al. South Med J. 2023 May;116(5):427-433. doi: 10.14423/SMJ.0000000000001546. South Med J. 2023. PMID: 37137479 Free PMC article. Review.
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hospital admission) severe COVID-19 infection. ...Clinical improvement was noted in six patients who were discharged from the ICU. CONCLUSIONS: …
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hosp …
Treatment for emerging viruses: Convalescent plasma and COVID-19.
Brown BL, McCullough J. Brown BL, et al. Transfus Apher Sci. 2020 Jun;59(3):102790. doi: 10.1016/j.transci.2020.102790. Epub 2020 Apr 20. Transfus Apher Sci. 2020. PMID: 32345485 Free PMC article. Review.
This report summarizes existing literature around convalescent plasma as a therapeutic option for COVID-19. It also includes recommendations for establishing a convalescent plasma program, enhancement considerations for convalescent plasma …
This report summarizes existing literature around convalescent plasma as a therapeutic option for COVID-19. It also includes r …
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.
Barone P, DeSimone RA. Barone P, et al. Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12. Transfusion. 2020. PMID: 32374891 Free PMC article. Review.
There are many clinical trials studying treatment of, and prophylaxis against, COVID-19 using convalescent plasma. In addition to clinical trials, the FDA also allows treatment through two other pathways: the "Expanded Access to Convalescent Plasma for …
There are many clinical trials studying treatment of, and prophylaxis against, COVID-19 using convalescent plasma. In addition …
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results.
Oliveira FA, Nucci MP, Rego GNA, Alves ADH, Marti LC, Nucci LP, Mamani JB, Gamarra LF. Oliveira FA, et al. Einstein (Sao Paulo). 2021 Apr 19;19:eRW6186. doi: 10.31744/einstein_journal/2021RW6186. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 33886937 Free PMC article. Review.
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preliminary results of passive immunization through convalescent plasma. We performed a search at the major databases of interventional clinical trial p …
The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-2, addressing the preliminary results of pas …
Convalescent Plasma for Covid-19.
Joyner MJ, Pirofski LA. Joyner MJ, et al. N Engl J Med. 2022 Sep 8;387(10):955. doi: 10.1056/NEJMc2208338. N Engl J Med. 2022. PMID: 36069882 No abstract available.
Convalescent Plasma for Covid-19.
Paneth N. Paneth N. N Engl J Med. 2022 Sep 8;387(10):955. doi: 10.1056/NEJMc2208338. N Engl J Med. 2022. PMID: 36069883 No abstract available.
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
Ouyang J, Isnard S, Lin J, Fombuena B, Peng X, Routy JP, Chen Y. Ouyang J, et al. Front Immunol. 2020 Sep 23;11:570063. doi: 10.3389/fimmu.2020.570063. eCollection 2020. Front Immunol. 2020. PMID: 33072111 Free PMC article. Review.
However, for seriously ill patients, no specific treatments are currently available. Convalescent plasma therapy (CPT), a passive immunotherapy, involves infusing plasma from recovered people into actively infected people, and is thought to be a specific inte …
However, for seriously ill patients, no specific treatments are currently available. Convalescent plasma therapy (CPT), a pass …
Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective.
Kanj S, Al-Omari B. Kanj S, et al. Viruses. 2021 May 7;13(5):849. doi: 10.3390/v13050849. Viruses. 2021. PMID: 34066932 Free PMC article. Review.
The treatment spectrum primarily includes ventilation support augmented with repurposed drugs and/or convalescent plasma transfusion (CPT) from recovered COVID-19 patients. ...However, early intervention (preferably within 3 days), recruitment of donors, and plas …
The treatment spectrum primarily includes ventilation support augmented with repurposed drugs and/or convalescent plasma trans …
COVID-19 convalescent plasma: Interim recommendations from the AABB.
Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR. Cohn CS, et al. Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7. Transfusion. 2021. PMID: 33586160 Free PMC article. Review. No abstract available.
3,314 results